We are live on ! Find out more
LJAC

L.J. Altfest & Co Portfolio holdings

AUM $1.03B
1-Year Est. Return 36.74%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+36.74%
3 Year Est. Return
+90.25%
5 Year Est. Return
+88.42%
10 Year Est. Return
+223.54%
AUM
$604M
AUM Growth
+$70.2M
Cap. Flow
+$43.7M
Cap. Flow %
7.24%
Top 10 Hldgs %
41.87%
Holding
285
New
26
Increased
83
Reduced
130
Closed
29
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
176
Johnson Controls International
JCI
$83.4B
$387K 0.06%
6,052
KXI icon
177
iShares Global Consumer Staples ETF
KXI
$1.09B
$386K 0.06%
6,471
-1,322
-17% -$76.6K
VTI icon
178
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$386K 0.06%
2,018
+136
+7% +$26.2K
VTC icon
179
Vanguard Total Corporate Bond ETF
VTC
$1.67B
$384K 0.06%
5,172
-130
-2% -$9.58K
CFG icon
180
Citizens Financial Group
CFG
$29.7B
$382K 0.06%
9,707
+39
+0.4% +$1.52K
INFY icon
181
Infosys
INFY
$47B
$379K 0.06%
21,050
-99
-0.5% -$1.84K
SCHA icon
182
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$379K 0.06%
18,704
+818
+5% +$16.8K
VSGX icon
183
Vanguard ESG International Stock ETF
VSGX
$6.72B
$379K 0.06%
+7,702
New +$366K
NEA icon
184
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.24B
$377K 0.06%
33,144
+27
+0.1% +$295
VPU
185
Vanguard Utilities ETF
VPU
$8.08B
$374K 0.06%
+2,439
New +$361K
BAX icon
186
Baxter International
BAX
$12.3B
$371K 0.06%
+7,286
New +$391K
VRTX icon
187
Vertex Pharmaceuticals
VRTX
$132B
$370K 0.06%
1,280
-1,175
-48% -$358K
WFC icon
188
Wells Fargo
WFC
$268B
$366K 0.06%
8,870
-37
-0.4% -$1.64K
CSGP icon
189
CoStar Group
CSGP
$12.8B
$359K 0.06%
4,644
-17
-0.4% -$1.33K
IQV icon
190
IQVIA
IQV
$43.1B
$359K 0.06%
1,754
-25
-1% -$5.07K
PDD icon
191
Pinduoduo
PDD
$113B
$359K 0.06%
+4,398
New +$306K
EPAM icon
192
EPAM Systems
EPAM
$6.38B
$354K 0.06%
1,080
+3
+0.3% +$1.02K
SO icon
193
Southern Company
SO
$100B
$354K 0.06%
4,960
+408
+9% +$27.3K
IVW icon
194
iShares S&P 500 Growth ETF
IVW
$76.1B
$351K 0.06%
6,000
GILD icon
195
Gilead Sciences
GILD
$182B
$348K 0.06%
4,048
-263
-6% -$20.8K
BMRN icon
196
BioMarin Pharmaceuticals
BMRN
$12.9B
$346K 0.06%
3,339
-21
-0.6% -$1.97K
MCD icon
197
McDonald's
MCD
$182B
$346K 0.06%
1,312
-131
-9% -$34.6K
SCHO icon
198
Schwab Short-Term US Treasury ETF
SCHO
$15.3B
$346K 0.06%
14,358
-7,148
-33% -$172K
PYPL icon
199
PayPal
PYPL
$46.2B
$338K 0.06%
4,740
+57
+1% +$4.56K
MGK icon
200
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.4B
$335K 0.06%
9,725
-1,435
-13% -$51.4K

Similar funds

L.J. Altfest & Co's Q4 2022 Portfolio in Review

As of Q4 2022, L.J. Altfest & Co held 285 positions worth $604M, up 13% from $533M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

L.J. Altfest & Co deployed $43.7M of net new capital in Q4 2022, opening 26 new positions and adding to 83 existing holdings. Its largest new stake was Innovator 20+ Year Treasury Bond 9 Buffer ETF July: 2,214,644 shares worth $43M.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, up from 74% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR Portfolio Long Term Treasury ETF, an estimated $42.3M trimmed.

  • L.J. Altfest & Co's largest Q4 2022 buy was Innovator 20+ Year Treasury Bond 9 Buffer ETF July: 2,214,644 shares worth $43M.
  • L.J. Altfest & Co added most to Matthews Asia Innovators Active ETF in Q4 2022, an estimated $22.3M increase.
  • L.J. Altfest & Co's biggest Q4 2022 reduction was State Street SPDR Portfolio Long Term Treasury ETF, cutting an estimated $42.3M.
  • L.J. Altfest & Co fully exited PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund in Q4 2022, selling an estimated $10.9M.
  • L.J. Altfest & Co's ten largest holdings make up 42% of its $604M portfolio in Q4 2022.
  • L.J. Altfest & Co opened 26 new positions and closed 29 in Q4 2022.
  • L.J. Altfest & Co's portfolio value rose 13% quarter-over-quarter to $604M.

Based on L.J. Altfest & Co's 13F filing for Q4 2022, filed 2 Feb 2023.